The clinical characteristics of patients in the high TMEM60 expression group were mainly 1p19q non-codel, IDH wild-type, >42 years of age, WHO III–WHO IV grade, increased immune cells and stromal cells, decreased tumor purity, and increased activation of immune cells and pathways. The gene discussed is TMEM60; the disease is neoplasm.